Fig. 4From: KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation dataKAZN expression in ovarian cancer and survival analysis based on TCGA database. A Box plot, illustrating median expression levels of KAZN in normal ovarian tissue (Left, from GTEx) and ovarian tumors (Right, from TCGA). B Kaplan-Meier survival curve, illustrating overall survival for patients who had a tumor with up-regulated or down-regulated KAZNBack to article page